Research progress on Limosilactibacilus reuteri in diseases

Area of Science:

• Microbiology
• Probiotics
• Gut Microbiota

Background:

• Limosilactibacilus reuteri (L. reuteri) is a gram-positive probiotic bacterium.
• Certain strains are approved for human health products in China.
• L. reuteri plays a role in gut health and immune function.

Purpose of the Study:

• To review the research history of L. reuteri.
• To elucidate the mechanisms by which L. reuteri affects host health and disease.
• To discuss the dual role of L. reuteri in health and disease.

Main Methods:

• Literature review of existing studies on L. reuteri.
• Analysis of L. reuteri's direct and indirect effects on host organisms.
• Examination of L. reuteri's association with various diseases.

Main Results:

• L. reuteri modulates the gut microbiota and host physiology.
• Deficiency in L. reuteri is linked to digestive, autoimmune, endocrine, and reproductive diseases.
• Some studies indicate L. reuteri can promote disease progression.

Conclusions:

• L. reuteri exhibits a dual role, generally beneficial but with potential to aggravate diseases.
• Further research is required to fully understand L. reuteri's impact and its future as a probiotic.
• Mechanisms of L. reuteri's health benefits and disease exacerbation require deeper investigation.